A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation	Antibody Mediated Rejection of Lung Transplant	Recruiting	Phase 1	2026-08-27		NCT06990711

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Heart, Lung, and Blood Institute (NHLBI)	791
University of Utah	319
Washington University School of Medicine	475

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Utah	Saint Lake City	United States	1
Washington University School, of Medicine, Barnes-Jewish Hospital	St Louis	United States	1

Clinical trials